Navigation Links
Silence Therapeutics Provides Corporate and Development Update
Date:11/8/2011

LONDON, November 8, 2011 /PRNewswire/ --

Silence Therapeutics plc (AIM: SLN) ("Silence" or the "Company"), a leading RNA interference (RNAi) therapeutics company, today provides an update on recent business and clinical developments.

Expansion of business development team

Silence today announces the appointment of Dr Georg Buchner as VP Business Development. Georg will work with Tony Sedgwick who was appointed as Silence's Chief Business Officer in September as part of the Company's strategy to continue to broaden its collaborations with global pharmaceutical and biotechnology companies. Georg was formerly VP of Corporate & Business Development at Novacta Biosystems Ltd. Prior to joining Novacta, Georg was Business Development Director at Haptogen Ltd and was instrumental in the sale of the business to Wyeth (now part of Pfizer) in 2007. Georg gained a PhD in Molecular Genetics from King's College London and an MBA from The University of Cambridge's Judge Institute of Management.

Atu027 trial update

Results from the ongoing Phase I trial of Atu027, Silence's lead siRNA development programme for the treatment of advanced solid cancer, now confirm that 10 out of 27 (37%) patients treated to date have shown stable disease after the treatment phase of the trial. Dosing of the first patient in cohort 10 of the 11 cohort trial has now commenced and the trial is on track to complete recruitment in early 2012 with results reported by mid-2012.  Atu027 incorporates AtuPLEX™, Silence's proprietary delivery technology that transports RNAi molecules to the target site with high specificity.

Atu134 development update

Following further encouraging data generate
'/>"/>

SOURCE Silence Therapeutics Plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. National Ovarian Cancer Coalition and PureOlogy to Host First Annual NOCC and PureOlogys Walk to Break the Silence on Ovarian Cancer
2. Silence Therapeutics to Present at 12th Annual BIO CEO & Investor Conference
3. Silence Therapeutics Appoints New Vice President of Research
4. Silence Therapeutics Issued Novel RNAi Patent Covering High-Value Cancer Target in United States
5. Silence Therapeutics Expands RNAi Structural Modification IP Portfolio With Issuance of New U.S. Patent
6. Silence Therapeutics Partner Quark Signs Exclusive Option Agreement With Novartis for Development and Commercialisation of QPI-1002
7. Silence Therapeutics Receives Comprehensive Protection for RNAi Structural Modification Technology in Single European Patent
8. Silence Therapeutics Lead RNA Interference Therapeutic Prevents Spread of Cancer to Lungs
9. Silence Therapeutics Issued Japanese Patent Covering its Core RNA Interference (RNAi) Technology
10. Silence Therapeutics Signs Collaboration With Mirna Therapeutics to Evaluate Delivery of Novel microRNA Therapeutics
11. Halozyme Therapeutics Reports 2008 Second Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... (PRWEB) December 19, 2014 Charm Sciences ... test for the Detection of Aflatoxin M1 in raw ... receive independent third party validation. The peer reviewed report ... of the Institute for Agricultural and Fisheries Research (ILVO-T&V) ... , Aflatoxin B1, the most toxic aflatoxin and ...
(Date:12/19/2014)... , Dec. 19, 2014  Roche (SIX: RO, ... Bina Technologies, Inc. (Bina), a privately held company ... , USA. Bina provides a big data platform ... sequencing (NGS) data. Bina,s proprietary on-market Genomic Management ... academic researchers to perform fast and scalable analyses ...
(Date:12/19/2014)... 19, 2014 Research and Markets ... the "Technology Innovations in Smart Fabrics (Technical ... http://photos.prnewswire.com/prnh/20130307/600769 The ... offers a detailed assessment on technological advancements and ... 1. The Smart Fabrics market ...
(Date:12/19/2014)... (PRWEB) December 18, 2014 LayerBio is ... ophthalmology and wound care. The National Eye Institute (NEI) ... LayerBio a Phase I SBIR grant to develop a ... are the most common cause of vision loss in ... blindness worldwide. According to Dr. Ken Mandell, LayerBio’s Founder ...
Breaking Biology Technology:Charm Sciences Achieves Independent Validation of First 15 Minute Quantitative Screening Method for Aflatoxin M1 2Roche acquires Bina Technologies and enters the genomic informatics market 2Roche acquires Bina Technologies and enters the genomic informatics market 3Technology Innovations in Smart Fabrics (Technical Insights) 2LayerBio Awarded NIH Grant to Develop a Drug Delivery Device for Cataract Surgery 2
... , DUBAI, UAE, October 29 , ... Record Time of Two Months , In ... US-based,healthcare software solutions provider has successfully implemented the,Healthcare Information System (HIS) ... announced today. , Research shows that doctors ...
... NeurogesX, Inc. (Nasdaq: NGSX ), a biopharmaceutical company ... announced today that Anthony DiTonno, President and Chief Executive ... in New York City: the Oppenheimer & Co. 20th ... and the Lazard Capital Markets 6th Annual Healthcare Conference, ...
... , WARSAW, Ind., Oct. 28 Zimmer Holdings, Inc. ... OMeGA Medical Grants Association LLC (OMeGA) has chosen its ... third party administrator for graduate medical education to which ... for the 2009-2010 academic year. , OMeGA received more ...
Cached Biology Technology:Pragmedic Implements World-Class Healthcare Solution for Emaar Healthcare 2NeurogesX to Present at Two November Conferences 2NeurogesX to Present at Two November Conferences 3Zimmer Holdings Announces OMeGA Graduate Medical Education Grant Recipients 2Zimmer Holdings Announces OMeGA Graduate Medical Education Grant Recipients 3Zimmer Holdings Announces OMeGA Graduate Medical Education Grant Recipients 4
(Date:11/21/2014)... 18, 2014 According to a ... Systems (Video, RFID, Access Control, Intrusion Detection, Parking Management, ... Government), Component Service Geography - Global Forecasts to 2020", ... projected to be around $25 Billion in 2014 and ... at a CAGR of 8.69%. Browse 116 ...
(Date:11/21/2014)... Nov. 20, 2014 C-Labs LLC, a leading ... of Things (IoT), today announced the appointment of ... officer. Previously a strategic advisor to the firm, Mr. ... Mr. Traynor is based out of the C-Labs office ... to Chris Muench , Chief Executive Officer. ...
(Date:11/18/2014)... , Nov. 17, 2014   ... and EMC collaborate to develop The Partners Data ... , The Partners Data Lake will allow researcher ... improve diagnostics, treatment and the lives of patients ... research and clinical activities across the Partners system, ...
Breaking Biology News(10 mins):Industrial Security Systems Market Worth $38 Billion by 2020 2Industrial Security Systems Market Worth $38 Billion by 2020 3C-Labs Names Former Microsoft and Bsquare Executive as Chief Operating Officer 2Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 2Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 3Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 4Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 5
... and Systems in Critical Infrastructure Industries Including Water, ... 11 Uniloc USA, Inc., the ... availability of NetAnchor(TM), a unique solution designed specifically ... in industries designated as critical infrastructure, including water, ...
... Saves Time and Increases EfficiencyWALL, N.J., May ... Board: BKYI), a leader in finger-based biometric ... announced that Minnesota counties are deploying BIO-key,s ... a new paperless criminal charging, or eCharging ...
... and disease have decimated shellfish populations in many ... Smithsonian scientists, led by Whitman Miller, ecologist at ... have discovered another serious threat to these valuable ... contribute to the acidification of open ocean, coastal ...
Cached Biology News:Uniloc Unveils Industry-First Authentication Technology for Comprehensive Protection of Critical Infrastructure 2Minnesota Counties Secure New Criminal Charging System With BIO-key(R) Fingerprint Biometrics 2Minnesota Counties Secure New Criminal Charging System With BIO-key(R) Fingerprint Biometrics 3Shellfish face an uncertain future in a high CO2 world 2Shellfish face an uncertain future in a high CO2 world 3
... of gene expression) technology allows ... profiles generated by SAGE are ... transcripts making it possible to ... Kit is designed to make ...
Sheep Serum US Origin...
... For the ultimate in utility and ... to meet the needs of the researcher. ... interior dimensions or as sheet material that ... enclosures. These isolators are autoclavable and non-cytotoxic ...
2,4-Dinitrophenyl hapten is conjugated to Human Serum Albumin (HSA) protein through lysine....
Biology Products: